In Brief: Lifecore Biomedical
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical: Submission of a premarket approval application for firm's Intergel adhesion prevention solution for use in female abdominal surgery is targeted for June, the company says. The same time frame is set for European market launch of Intergel. Preliminary study data show that patients receiving Intergel post-surgery had a statistically significant reduction in abdominal adhesions compared to control patients, Lifecore reports. Johnson & Johnson's Ethicon unit is Lifecore's worldwide exclusive marketing partner...